Differential changes in serum uric acid concentrations in sibutramine promoted weight loss in diabetes: results from four weeks of the lead-in period of the SCOUT trial

BACKGROUND AND AIMS: Elevated levels of serum uric acid are associated with an increased risk of cardiovascular morbidity and mortality. The response of uric acid to weight loss therapy (lifestyle plus sibutramine) in an overweight and obese cardiovascular high risk population was studied. METHODS A...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersson, Charlotte, Weeke, Peter, Brendorp, Bente, Køber, Lars, Fosbøl, Emil L, Sharma, Arya M, Finer, Nick, Caterson, Ian D, Rode, Richard A, James, Philip T, Torp-Pedersen, Christian
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768730/
https://www.ncbi.nlm.nih.gov/pubmed/19828038
http://dx.doi.org/10.1186/1743-7075-6-42

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768730/
https://www.ncbi.nlm.nih.gov/pubmed/19828038
http://dx.doi.org/10.1186/1743-7075-6-42

Ejemplares similares